Already making big profits from its COVID-19 vaccine, Pfizer looks set to bolt on another big revenue stream with its oral antiviral drug Paxlovid after scoring a $5.3 billion order for the drug ...

Genmab has shattered recent records with its Nasdaq listing, raising $506 million to help it advance multiple antibody projects, including in-house candidates. The company, notable for its ...